Published in Pediatr Nephrol on October 18, 2007
Childhood extraordinary daytime urinary frequency-a case series and a systematic literature review. Pediatr Nephrol (2008) 0.81
Spontaneous urinary calcium oxalate crystallization in hypercalciuric children. Pediatr Nephrol (2009) 0.75
Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med (2002) 8.79
Problems of reporting genetic associations with complex outcomes. Lancet (2003) 8.11
A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med (1993) 5.87
Association studies of genetic polymorphisms and complex disease. Lancet (2000) 4.37
The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stone of renal origin. Br J Surg (1958) 3.11
Assessment of calcium excretion from the urinary calcium/creatinine ratio. Lancet (1959) 2.81
Urinary excretion of calcium and magnesium in children. Arch Dis Child (1974) 2.44
R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney Int (2007) 2.01
Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation. J Bone Miner Res (2001) 1.93
A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. N Engl J Med (1975) 1.71
Familial idiopathic hypercalciuria. N Engl J Med (1979) 1.61
Segregation of urine calcium excretion in families ascertained for nephrolithiasis: evidence for a major gene. Kidney Int (2005) 1.50
Family pattern of idiopathic hypercalciuria and its subtypes. J Urol (1996) 1.46
Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med (1982) 1.27
Genetic factors in calcium oxalate stone disease. J Urol (1995) 1.06
Genetics of hypercalciuria and calcium nephrolithiasis: from the rare monogenic to the common polygenic forms. Am J Kidney Dis (2004) 1.05
Pathophysiology of hypercalciuria in children. Pediatr Nephrol (2007) 0.99
Urinary calcium excretion in healthy children and adolescents. Pediatr Nephrol (1999) 0.97
Medical therapy and new approaches to management of urolithiasis. Urol Clin North Am (2000) 0.96
Renal and absorptive hypercalciuria: a metabolic disturbance with varying and interchanging modes of expression. Pediatrics (1996) 0.95
Quantitative trait loci for hypercalciuria in a rat model of kidney stone disease. J Am Soc Nephrol (2003) 0.95
Evaluation of bone metabolism in children with hypercalciuria. Semin Nephrol (1989) 0.91
Urinary calcium is a determinant of bone mineral density in elderly men participating in the InCHIANTI study. Kidney Int (2005) 0.90
Idiopathic hypercalciuria in children--how valid are the existing diagnostic criteria? Pediatr Nephrol (2004) 0.89
Familial absorptive hypercalciuria in a large kindred. J Urol (1981) 0.88
Genetic hypercalciuric stone-forming rats. Curr Opin Nephrol Hypertens (1999) 0.88
Pathophysiology and treatment of idiopathic hypercalciuria. Curr Opin Rheumatol (1998) 0.87
Renal mass and serum calcitriol in male idiopathic calcium renal stone formers: role of protein intake. J Clin Endocrinol Metab (1995) 0.84
Familial forms of hypercalciuria. J Urol (1989) 0.82
Dietary calcium and serum 1,25-(OH)2-vitamin D concentrations as determinants of calcium balance in healthy men. Kidney Int (1984) 0.80
Family investigations in idiopathic hypercalciuria. Eur J Pediatr (1993) 0.78
No evidence for point mutations of the calcium-sensing receptor in familial idiopathic hypercalciuria. Nephrol Dial Transplant (2001) 0.78
Re: Family pattern of idiopathic hypercalciuria and its subtypes. J Urol (1996) 0.78
History of kidney stones and the risk of coronary heart disease. JAMA (2013) 3.23
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04
Soda and other beverages and the risk of kidney stones. Clin J Am Soc Nephrol (2013) 1.82
Medullary sponge kidney: state of the art. Nephrol Dial Transplant (2012) 1.76
Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: a randomized controlled trial. Nephrol Dial Transplant (2008) 1.56
Familial clustering of medullary sponge kidney is autosomal dominant with reduced penetrance and variable expressivity. Kidney Int (2012) 1.52
Low level exposure to cadmium increases the risk of chronic kidney disease: analysis of the NHANES 1999-2006. BMC Public Health (2010) 1.25
Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial. Am J Clin Nutr (2009) 1.24
Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J Am Soc Nephrol (2002) 1.21
Long-term treatment with potassium citrate and renal stones in medullary sponge kidney. Clin J Am Soc Nephrol (2010) 1.18
Prolonged conservative treatment for frail elderly patients with end-stage renal disease: the Verona experience. Nephrol Dial Transplant (2007) 1.10
Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells. J Biol Chem (2011) 1.07
Phenotypic and genetic heterogeneity in Dent's disease--the results of an Italian collaborative study. Nephrol Dial Transplant (2006) 1.07
Quantitave and qualitative changes in vascular endothelial growth factor gene expression in glomeruli of patients with type 2 diabetes. Eur J Endocrinol (2004) 1.00
Genetics and calcium nephrolithiasis. Kidney Int (2010) 0.99
Regulation of heparanase by albumin and advanced glycation end products in proximal tubular cells. Biochim Biophys Acta (2011) 0.96
Calcium kidney stones are associated with a haplotype of the calcium-sensing receptor gene regulatory region. Nephrol Dial Transplant (2010) 0.95
Renal transplantation from non-heart- beating donors: a review of the European experience. J Nephrol (2003) 0.93
Prevalence of renal stones in an Italian urban population: a general practice-based study. Urol Res (2012) 0.93
Update on primary hypercalciuria from a genetic perspective. J Urol (2008) 0.92
Bone disease in medullary sponge kidney and effect of potassium citrate treatment. Clin J Am Soc Nephrol (2009) 0.92
Autosomal dominant hypocalcemia with mild type 5 Bartter syndrome. J Nephrol (2006) 0.92
Intestinal calcium absorption is associated with bone mass in stone-forming women with idiopathic hypercalciuria. Am J Kidney Dis (2003) 0.91
Urinary calcium is a determinant of bone mineral density in elderly men participating in the InCHIANTI study. Kidney Int (2005) 0.90
Roles of calcium-sensing receptor (CaSR) in renal mineral ion transport. Curr Pharm Biotechnol (2009) 0.90
Dietary habits in women with recurrent idiopathic calcium nephrolithiasis. J Transl Med (2012) 0.90
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition. J Transl Med (2012) 0.89
Peritoneal ultrafiltration in refractory heart failure: a cohort study. Perit Dial Int (2013) 0.89
Small effective population size and genetic homogeneity in the Val Borbera isolate. Eur J Hum Genet (2012) 0.89
Diagnostic accuracy of a reagent strip for assessing urinary albumin excretion in the general population. Nephrol Dial Transplant (2008) 0.89
Calcium-sensing receptor gene polymorphisms in patients with calcium nephrolithiasis. Curr Opin Nephrol Hypertens (2012) 0.89
Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. Clin Chem (2011) 0.89
Perforin, Granzyme B, and fas ligand for molecular diagnosis of acute renal-allograft rejection: analyses on serial biopsies suggest methodological issues. Transplantation (2006) 0.89
Polymorphisms at the regulatory regions of the CASR gene influence stone risk in primary hyperparathyroidism. Eur J Endocrinol (2010) 0.87
Identification of GDNF gene sequence variations in patients with medullary sponge kidney disease. Clin J Am Soc Nephrol (2010) 0.86
Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. Kidney Int (2003) 0.86
Calcium-sensing receptor and calcium kidney stones. J Transl Med (2011) 0.86
When to suspect a genetic disorder in a patient with renal stones, and why. Nephrol Dial Transplant (2013) 0.86
Treating elderly people with diabetes and stages 3 and 4 chronic kidney disease. Clin J Am Soc Nephrol (2008) 0.85
Idiopathic calcium nephrolithiasis: a review of pathogenic mechanisms in the light of genetic studies. Am J Nephrol (2014) 0.85
Decreased transcriptional activity of calcium-sensing receptor gene promoter 1 is associated with calcium nephrolithiasis. J Clin Endocrinol Metab (2013) 0.84
Heparin reduces glomerular infiltration and TGF-beta protein expression by macrophages in puromycin glomerulosclerosis. J Nephrol (2003) 0.84
Heparanase as a target in cancer therapy. Curr Cancer Drug Targets (2014) 0.84
Sulodexide and glycosaminoglycans in the progression of renal disease. Nephrol Dial Transplant (2014) 0.84
Dent's disease and prevalence of renal stones in dialysis patients in Northeastern Italy. J Hum Genet (2005) 0.84
Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. Am J Med (2010) 0.83
The role of glycosaminoglycans and sulodexide in the treatment of diabetic nephropathy. Treat Endocrinol (2006) 0.82
A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia. Eur J Endocrinol (2012) 0.82
University courses, eating problems and muscle dysmorphia: are there any associations? J Transl Med (2014) 0.82
Nutrition in calcium nephrolithiasis. J Transl Med (2013) 0.81
Polymorphism of vitamin D receptor gene start codon in patients with calcium kidney stones. J Nephrol (2002) 0.81
GAPDH as housekeeping gene at renal level. Kidney Int (2004) 0.81
Predictive model for delayed graft function based on easily available pre-renal transplant variables. Intern Emerg Med (2014) 0.81
Oxidation of Met1606 in von Willebrand factor is a risk factor for thrombotic and septic complications in chronic renal failure. Biochem J (2012) 0.81
Calcimimetic R-568 effects on activity of R990G polymorphism of calcium-sensing receptor. J Mol Endocrinol (2010) 0.80
Discounting the efficacy of sulodexide in diabetic nephropathy is premature. Am J Kidney Dis (2012) 0.80
Cadmium exposure and kidney stone formation in the general population--an analysis of the National Health and Nutrition Examination Survey III data. J Endourol (2011) 0.80
Metabolic syndrome, cardiovascular disease, and risk for chronic kidney disease in an Italian cohort: analysis of the INCIPE study. Metab Syndr Relat Disord (2011) 0.79
Hermann Boerhaave and lithotomy: what he thought about it. Am J Nephrol (2002) 0.79
Age dependence of within-subject biological variation of nine common clinical chemistry analytes. Clin Chem Lab Med (2012) 0.79
Henoch-Schönlein purpura and Crohn's disease in a family. J Nephrol (2006) 0.79
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered. Int J Nephrol Renovasc Dis (2010) 0.78
Aspergillus fumigatus peritonitis in ambulatory peritoneal dialysis: a case report and notes on the therapeutic approach. Nephrology (Carlton) (2005) 0.78
Excessive signal transduction of gain-of-function variants of the calcium-sensing receptor (CaSR) are associated with increased ER to cytosol calcium gradient. PLoS One (2013) 0.78
A validated model of disease progression in IgA nephropathy. J Nephrol (2006) 0.78
Metabolic and toxicological considerations for diuretic therapy in patients with acute heart failure. Expert Opin Drug Metab Toxicol (2011) 0.78
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. J Nephrol (2015) 0.78
Recent data concerning heparanase: focus on fibrosis, inflammation and cancer. Biomol Concepts (2015) 0.78
Effect of oral treatment with the glycosaminoglycan sulodexide on peritoneal transport in CAPD patients. Perit Dial Int (2004) 0.78
Identification of a novel splice site mutation of CLCN5 gene and characterization of a new alternative 5' UTR end of ClC-5 mRNA in human renal tissue and leukocytes. J Hum Genet (2003) 0.78
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. J Transl Med (2013) 0.78
mTOR inhibitors and renal allograft: Yin and Yang. J Nephrol (2014) 0.77
Percutaneous and transureteral biopsies of renal papillae: safe and appropriate procedures for in vivo histologic analysis in stone formers. J Endourol (2011) 0.77
Randall's plaques, plugs and the clinical workup of the renal stone patient. Urolithiasis (2014) 0.77
[Hyperparathyroidism as a cardiovascular risk factor in chronic kidney disease: an update from a biological-cellular perspective]. G Ital Nefrol (2011) 0.77
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Arch Ital Urol Androl (2015) 0.77
Influence of lean and fat mass on bone mineral density and on urinary stone risk factors in healthy women. J Transl Med (2013) 0.77
Dialysis-related transcriptomic profiling: the pivotal role of heparanase. Exp Biol Med (Maywood) (2013) 0.77
Risk of nephrolithiasis in primary hyperparathyroidism is associated with two polymorphisms of the calcium-sensing receptor gene. J Nephrol (2014) 0.77
Dietary fatty acid supplementation modulates the urinary excretion of calcium and oxalate in the rat. Insight into calcium lithogenesis. Nephron (2002) 0.77
Detection of a large deletion in the P-selectin (SELP) gene. Mol Cell Probes (2009) 0.77
Early activation of fibrogenesis in transplanted kidneys: a study on serial renal biopsies. Exp Mol Pathol (2009) 0.76
Evening primrose oil supplementation increases citraturia and decreases other urinary risk factors for calcium oxalate urolithiasis. J Urol (2009) 0.76
Strategies to safely interfere with prostanoid activity while avoiding adverse renal effects: could COX-2 and COX-LOX dual inhibition be the answer? Nephrol Dial Transplant (2002) 0.76
Pathophysiology of hypercalciuria. Am J Physiol Renal Physiol (2007) 0.76
Is the simian virus SV40 associated with idiopathic focal segmental glomerulosclerosis in humans? J Nephrol (2003) 0.76
Spontaneous calcification process in primary renal cells from a medullary sponge kidney patient harbouring a GDNF mutation. J Cell Mol Med (2015) 0.76
Unusual renal presentation of Fabry disease in a female patient. Nat Rev Nephrol (2009) 0.75
Gene expression analysis in microdissected renal biopsy. Kidney Int (2004) 0.75
Nephrolithiasis: nutrition as cause or therapeutic tool. J Transl Med (2013) 0.75
Ayurvedic medicine and NADPH oxidase: a possible approach to the prevention of ESRD in hyperoxaluria. Nephrol Dial Transplant (2011) 0.75
Anaemia in diabetic renal failure: is there a role for early erythropoietin treatment in preventing cardiovascular mortality? Diabetes Obes Metab (2007) 0.75
It's time for a practical method quantifying vascular calcification. J Transl Med (2014) 0.75
Regarding 'Early postoperative serum cystatin C predicts severe acute kidney injury following pediatric cardiac surgery'. Kidney Int (2012) 0.75